Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Chisy who wrote (1394)	8/10/1999 8:36:00 PM
From: vestor	Read Replies (2) \| Respond to of 1837

DRMD said that the BC pill approval is expected within this qtr. This qtr. ends 9/30..... Any day now... Regarding the Cenestin 1.25 dosage request, a friend in the Drug business says it generally takes two to three months for the FDA to decide. We have the potential here to pick up two approvals that that had sales of 350 mil. in 1998. We should see some price appreciaion here. The next qtr. has an excellent head start given deferred revenue plus rampup expenses being accounted for in qtr. 2.... Lets hope the 5 previously approved drugs begin to contribute at least somewhat in the 3rd. although they should have a profound effect in the 4th. qtr.